Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mohana R. Velagapudi
Observed names:
Mohana R Velagapudi,
Mohana Velagapudi
Observed institutions:
John Deere (United States),
Elixir Medical (United States),
3D Medicines, Inc. (China)
OpenAlex ID:
A5037808099
Triptolide and Its Derivatives as Cancer Therapies
2019
·
Pawan Noel
, Daniel D. Von Hoff
, et al.
·
Trends in Pharmacological Sciences
·
313
First-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity
2023
·
Erkut Borazanci
, Ashok Saluja
, et al.
·
The Oncologist
·
31
PDF
The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: A phase I trial
2024
·
Sung Hee Lim
, Ashok Saluja
, et al.
·
Cancer Letters
·
17
Abstract CT165: Phase II open label trial of minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer
2019
·
David Propper
, Haiyong Han
, et al.
·
Cancer Research
·
6
Abstract CT218: Phase II open label trial of Minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer
2024
·
David Propper
, Erkut Borazanci
, et al.
·
Cancer Research
·
2
Abstract CT165: Phase II open label trial of minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer
2019
·
David Propper
, Haiyong Han
, et al.
·
Clinical Trials
·
2
Dipg-22. Triptolide as a Potentially Promising Therapy for Diffuse Midline Glioma
2023
·
Ludovica Ciani
, Sandra Laternser
, et al.
·
Neuro-Oncology
·
1
PDF
The Effect of Minnelide against SARS-CoV-2 in a Murine Model
2021
·
Marley C. Caballero Van Dyke
, Heather L. Mead
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Abstract 1891: Minnelide enhances the antitumor activity of pan-KRAS inhibitor RMC-6236 in preclinical models for pancreatic cancer.
2026
·
Edgar Banuelos
, Jaeger Moore
, et al.
·
Cancer Research
A phase 1 study to evaluate the safety and preliminary efficacy of minnelide given alone or in combination with paclitaxel in advanced gastric cancer.
2024
·
Sung Hee Lim
, Ashok K Saluja
, et al.
·
Journal of Clinical Oncology
PDF
Targeting super-enhancers in refractory pancreatic cancer
2023
·
David Propper
, Erkut Borazanci
, et al.
·
Pancreatology
Abstract A142: Drug combination screen to identify novel synergy with Minnelide
2019
·
Nanyun Tang
, Chris Sereduk
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
12
Citation count:
373
H-index:
4
I10-index:
3
Year
Topic
Type